A Clinical Study of Deedan-e-Ama (Intestinal Worms) to Assess the Effectiveness of Safoof-e-Deedan
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Completed
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Changes in subjective parameters such as abdominal pain,abdominal distension,decrease appetite,weight loss etc.
Study Overview
Brief Summary
Worm infestation (helminthiasis) is a major health problem in children, particularly in low-income and developing countries.. Helminthiasis caused by 3 groups of worms, nematodes (round worm). cestode (tape worm), and trematodes(flukes).Incidence of round worm infection is about one billion, whip worm infection is about 500 million and hook worn infection is about 900 million per population worldwide.
The clinical manifestations associated with worm infestation are abdominal pain, abdominal distention, growth retardation, nutritional deficiencies, pica, sleeplessness, irritability, anaemia when hookworm infestation is present, intestinal obstruction may be found, and some time larva of ascaris migrate to the lungs and cause ascaris pneumonia (Loeffler’s Syndrome), asthma-like manifestation, hepatomegaly, splenomegaly or encephalopathy.
In the Unani System of Medicine, the term worm infestation described as Deedan-e-Ama’a.
According to classical Unani literature the main cause of formation of Deedan- e-Ama’a (Intestinal worm) is only Balghami Rutoobat (Phlegmatic fluid small intestine. With the help of Hararat-e-Ghariba these Ratubate Balghamiyah become putrefied and lead to the formation of Deedan-e- Ama’a.,
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 5.00 Year(s) to 14.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients having history of abdominal pain, decrease appetite, weight loss etc.
- •Willing to participate in the study and follows instructions.
Exclusion Criteria
- •Patients below 5 years and above 14 years.
- •Patients who fail to follow up.
- •Known case of any systemic disease i.e.- RHD, Nephrotic Syndrome, Bronchial Asthma, Diabetes,TB, Liver and Blood born disease etc.
Outcomes
Primary Outcomes
Changes in subjective parameters such as abdominal pain,abdominal distension,decrease appetite,weight loss etc.
Time Frame: 10 days
Secondary Outcomes
- Changes in objective parameters like ova/cyst in Stool and Hb%, DLC and ESR in Blood(10 days)
Investigators
Dr Anjum Parveen
State Unani Medical College and Hospital